Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan
Cancer Medicine · 2025-08 · 14 (15)
DOI: 10.1002/cam4.71109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 02.08.2025. Verfasst von Shingo Hatakeyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Database Steering Committee of Japanese Urological Association, Tokyo, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Robotic Surgical Procedures, Postoperative Complications. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Japanese Urological Association.
Abstract (Originalsprache)
Background
Radical cystectomy (RC) is a standard‐of‐care treatment for muscle‐invasive bladder cancer (MIBC). However, there is a lack of data comparing the benefit of robot‐assisted radical cystectomy (RARC) with laparoscopic radical cystectomy (LRC) or open radical cystectomy (ORC) in Japan. We aimed to explore the safety of RARC compared with that of LRC or ORC using the Japanese National Clinical Database (NCD).
Methods
This retrospective study reviewed the data of 17,549 patients with MIBC who underwent radical cystectomy between February 2019 and December 2022 in the Japanese NCD. We compared the postoperative complications within 30 days between the surgical procedures using the Clavien–Dindo classification. Multivariable logistic regression analysis was conducted for grade ≥ 3 postoperative complications.
Results
Overall, 8308, 3101, and 6140 patients underwent RARC, LRC, and ORC, respectively. The rates of any grade and grade ≥ 3 postoperative complications within 30 days were significantly lower in the RARC group than in the ORC group. RARC had no significant difference in grade ≥ 3 postoperative complications in the ileal neobladder. Regarding any grade postoperative complications, RARC had a significantly lower rate of delirium, surgical site infection, sepsis, and gastrointestinal tract leakage than ORC. Multivariable logistic regression analysis revealed that the incidence of grade ≥ 3 postoperative complications was significantly lower in RARC (odds ratio, 0.83; 95% confidence interval, 0.72–0.95).
Conclusions
RARC had a lower complication rate compared with ORC. LRC had comparable outcomes to RARC. The findings of this study contribute to RARC as being the standard treatment for MIBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Clinical Database Steering Committee of Japanese Urological Association, Tokyo, Japan.
- Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Faculty of Medicine, Department of Urology, University of Toyama, Toyama, Japan.
- Faculty of Medicine, Department of Urology, University of Miyazaki, Miyazaki, Japan.
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
ORCID-Profile: Shingo Hatakeyama, Hiroyuki Yamamoto, Eiji Kikuchi
Förderung
- the Japanese Urological Association
Zitieren
APA
Hatakeyama, S., Yamamoto, H., Kitamura, H., Kamoto, T., & Kikuchi, E. (2025). Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan. Cancer Medicine, 14(15). https://doi.org/10.1002/cam4.71109
Vancouver
Hatakeyama S, Yamamoto H, Kitamura H, Kamoto T, Kikuchi E. Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan. Cancer Medicine. 2025;14(15). doi:10.1002/cam4.71109
BibTeX
@article{Hatakeyama2025,
author = {Hatakeyama, Shingo and Yamamoto, Hiroyuki and Kitamura, Hiroshi and Kamoto, Toshiyuki and Kikuchi, Eiji},
title = {Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {15},
doi = {10.1002/cam4.71109}
}
EUVIMED